|
KMID : 1150120190050010012
|
|
Asian Journal of Pain
2019 Volume.5 No. 1 p.12 ~ p.16
|
|
|
Effect of the Combination Treatment of Injection to Scar and Intercostal Nerve Block for Patients with Post-Zoster Neuralgia on the Trunk
|
|
Ahn Jong-Ho
Jang Seu-Ryang
Lee Sang-Bok
Kim Young-Woo
Lee Tae-Kyu
|
|
|
Abstract
|
|
|
Objective: The purpose of this study was to investigate the effect of the combination treatment of injection to scar and ICNB for patients with post-zoster neuralgia on the trunk.
Methods: We collect retrospective data on 23 patients undergoing combination treatment of injection to scar and ICNB in the management of neuropathic pain in patients with post-zoster neuralgia on the trunk during eight years beginning on January 1, 2011. We performed a combination treatment of injection to scar and intercostal nerve under fluoroscopy. The mixture of 3 mL of 0.5% bupivacaine containing 1 mg of triamcinolone and hyaluronic acid was injected around the scar and intercostal nerve under fluoroscopy. Pain intensity was measured using a visual analog score (VAS), quality of life scale (QOLS) and morphine consumption were measured at baseline and after management.
Results: The mean (±SD) VAS of baseline status was 7.3 (±0.56) before the combination treatment in the management of episodic pain with constant pain in patients with post-zoster neuralgia. VAS decreased to 2.26±1.05 after the combination treatment compared with baseline VAS and was sustained by 2.35±0.83 for 1 week and by 2.48±0.99 at 1 month. After 6 months, the pain remained at 2.52±1.16. In morphine consumption, the baseline doses were 104±126 mg/day that significantly reduced to 40±20 mg/day and 32±17 mg/day after one 1-month and 6-months postprocedure (p<0.001). The dose of gabapentin (1,200±300 mg/day) before treatment. The dose of gabapentin in the first month did not significantly decrease in taking gabapentin (1,000±300 mg/day) compared with the baseline dose (1,200±300 mg/day). Consumption after 6 months was also significantly reduced by 600±300 mg/day.
Conclusion: This clinical study suggests that the combination treatment of injection to scar and intercostal nerve block for patients with post-zoster neuralgia on the trunk is effective and safe for relieving post-zoster neuralgia
|
|
|
KEYWORD
|
|
|
Intercostal nerve block, Post-Zoster neuralgia, Subcutaneous injection
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|